| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/18/2007 | US20070014800 Cytokine zalpha11 ligand antibodies |
| 01/18/2007 | US20070014799 Antibody and use of the same |
| 01/18/2007 | US20070014798 Antibodies to dendritc cells and human dendritic cell populations and uses thereof |
| 01/18/2007 | US20070014794 preparing heteromultimeric polypeptides such as bispecific antibodies, bispecific immunoadhesins and antibody-immunoadhesin chimeras; yields of the heteromultimer over other unwanted end-products such as homomultimers |
| 01/18/2007 | US20070014793 Antibodies which activate an erythropoietin receptor |
| 01/18/2007 | US20070014790 Transcription control factor zhx3 |
| 01/18/2007 | US20070014785 Use of antibodies against CD20 for the treatment of the graft versus host disease |
| 01/18/2007 | US20070014775 Inducing an immune mediated destruction of tumor cells by administering to an animal, a mixture of attenuated tumor cells, said cells comprising a plurality of cell surface glycoproteins on which an alpha Gal epitope is present; anticacinogenic agents; tissue-targeted therapy; gene therapy |
| 01/18/2007 | US20070014774 Antitumor vaccination using allogeneic tumor cells expressing alpha (1,3)-galactosyltransferase |
| 01/18/2007 | US20070014769 Adenovirus vectors comprising meganuclease-type endonucleases, and related systems |
| 01/18/2007 | US20070014690 Multichamber device for processing of biological samples using high pressure |
| 01/18/2007 | DE112005000477T5 Mikroarraysubstrat für Biopolymere, Hybridisierungseinrichtungen und Hybridisierungsverfahren Microarray substrate for biopolymers, hybridization facilities and hybridization methods |
| 01/18/2007 | DE112004002318T5 Transkriptionsregulatoren und Verfahren dazu Transcriptional regulators and method therefor |
| 01/18/2007 | DE102006003777A1 Vorrichtung zur Verarbeitung biologischer Proben Apparatus for processing biological samples |
| 01/18/2007 | DE10019075B4 Verwendung von CD34 oder einem davon abgeleiteten Polypeptid als Zell-Oberflächen- bzw. Gentransfer-Marker Use of CD34 or a polypeptide derived as a cell-surface markers or gene transfer |
| 01/18/2007 | CA2625061A1 Novel bacterial proteins with pesticidal activity |
| 01/18/2007 | CA2615075A1 Tetrahymena heat inducible promoters and their use |
| 01/18/2007 | CA2614998A1 Production of sialylated glycoproteins in bryophytes |
| 01/18/2007 | CA2614659A1 Wheat pigment |
| 01/18/2007 | CA2614531A1 Nucleic acid agents for downregulating h19, and methods of using same |
| 01/18/2007 | CA2614512A1 Phage display using cotranslational translocation of fusion polypeptides |
| 01/18/2007 | CA2614421A1 Sp35 antibodies and uses thereof |
| 01/18/2007 | CA2614418A1 High tryptophan soybean meal |
| 01/18/2007 | CA2614361A1 Constitutive promoters from poplar and uses thereof |
| 01/18/2007 | CA2614353A1 Management of plant pathogens |
| 01/18/2007 | CA2614317A1 Compositions and methods comprising stinging capsules/cells for delivering a biologically active agent into a plant cell |
| 01/18/2007 | CA2614304A1 Novel phage display technologies |
| 01/18/2007 | CA2614186A1 Il-6 binding proteins |
| 01/18/2007 | CA2613984A1 Method for treating small volumes with electrical current |
| 01/18/2007 | CA2613619A1 Sp1 polypeptides, modified sp1 polypeptides and uses thereof |
| 01/18/2007 | CA2510657A1 Polypeptides with an activity in the mtbe degradation pathway and their use |
| 01/17/2007 | EP1744162A1 Cancer diagnosis and treatment using anti-robo1 antibody |
| 01/17/2007 | EP1743947A2 Method for diagnosing non-small cell lung cancers |
| 01/17/2007 | EP1743944A1 Novel method of screening |
| 01/17/2007 | EP1743943A1 Process for producing l-fuculose and process for producing l-fucose |
| 01/17/2007 | EP1743942A1 Recombinant virus vector for gene introduction in lymphocyte |
| 01/17/2007 | EP1743941A1 Novel mite allergen |
| 01/17/2007 | EP1743940A1 Cardioinhibitory/ antihypertensive novel endogenous physiologically active peptide |
| 01/17/2007 | EP1743939A2 Method for isolation of RNA from formalin-fixed paraffin-embedded tissue specimens |
| 01/17/2007 | EP1743938A1 Means and methods for displaying polypeptides on cells |
| 01/17/2007 | EP1743901A2 Oligonucleotides having A-DNA or B-DNA form |
| 01/17/2007 | EP1743653A1 Composition for increasing body height |
| 01/17/2007 | EP1743648A1 Method for treating inflammation |
| 01/17/2007 | EP1743523A1 Nonhuman transgenic animal as type 2 diabetes model |
| 01/17/2007 | EP1743041A1 Modified viral vector particles |
| 01/17/2007 | EP1743037A1 Method for the isolation of specific molecules which bind in a highly selective manner to selected target molecules |
| 01/17/2007 | EP1743030A2 Method and apparatus for bacterial transformation by electroporation with waveforms incorporating pulsed rf between 3 and 125 mhz |
| 01/17/2007 | EP1743029A1 Cell preparation |
| 01/17/2007 | EP1743028A2 Polyvalent viral vectors and a system for production thereof |
| 01/17/2007 | EP1743027A1 Mutant pneumolysin proteins |
| 01/17/2007 | EP1743026A1 I-dmoi derivatives with enhanced activity at 37°c and use thereof |
| 01/17/2007 | EP1742964A2 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation |
| 01/17/2007 | EP1742959A2 Nucleic acid ligands to immunoglobulin e and their use as atopic disease therapeutics |
| 01/17/2007 | EP1742958A2 Methods and compositions for the specific inhibition of gene expression by double-stranded rna |
| 01/17/2007 | EP1742661A2 Lipid compositions and use thereof |
| 01/17/2007 | EP1742658A2 Cellular permissivity factor for viruses, and uses thereof |
| 01/17/2007 | EP1742657A2 Immunization regimen with e4-deleted adenovirus prime and e1-deleted adenovirus boost |
| 01/17/2007 | EP1742653A2 Ammonium/ammonia transporter |
| 01/17/2007 | EP1742643A2 Modulation of glucose-6-phosphatase translocase expression |
| 01/17/2007 | EP1742527A2 Regulatory sequences for expressing gene products in plant reproductive tissue |
| 01/17/2007 | EP1654379A4 Methods and compositions for enhanced protein expression and purification |
| 01/17/2007 | EP1504095B1 Site specific listeria integration vectors and methods for using the same |
| 01/17/2007 | EP1495119B1 Method and apparatus for extracting nucleic acids from a complex mixture |
| 01/17/2007 | EP1399480B1 Multimers of class i major histocompatibility complexes containing modified beta2-microglobulin proteins |
| 01/17/2007 | EP1368474B1 Polynucleotide useful for modulating cancer cell proliferation |
| 01/17/2007 | EP1349945B1 Method for the production of a heterologous protein by a fungus |
| 01/17/2007 | EP1340088B1 In vitro methods of producing and identifying immunoglobulin molecules in eukaryotic cells |
| 01/17/2007 | EP1335646B1 Transgenic or recombinant non-human mammals for stop protein and their uses in screening psycho-active medicines |
| 01/17/2007 | EP1330516B1 Surface transfection and expression procedure |
| 01/17/2007 | EP1326995B1 Method for synthesising peptides, peptide mimetics and proteins |
| 01/17/2007 | EP1301630B1 Diagnostic method for the identification of foetal dna in a maternal sample |
| 01/17/2007 | EP1301539B1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/17/2007 | EP1281067B1 Method for high-throughput lead profiling |
| 01/17/2007 | EP1274745B1 Magnetic, silanised polyvinylalcohol-basedcarrier materials |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1259628B1 Methods for generating hypermutable yeast |
| 01/17/2007 | EP1228232B1 Recombinant sendai virus vector for introducing exogenous genes to airway epithelia |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1206556B1 Signal peptides isolated from lactococcus lactis |
| 01/17/2007 | EP1185299B1 Use of antibodies against cd20 for the treatment of the graft versus host disease |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | EP1179073B1 Process for the fermentative preparation of l-amino acids with amplification of the zwf gene |
| 01/17/2007 | EP1140174B1 Antagonist antibodies of cutaneous t cell-attracting chemokine (ctack) or vasoactive intestinal contractor (vic) chemokines |
| 01/17/2007 | EP1131430B1 Mitogenic regulators |
| 01/17/2007 | EP1087996B1 Glycosulfopeptides and methods of synthesis and use thereof |
| 01/17/2007 | EP1086207B1 Novel methods and interferon deficient substrates for the propagation of viruses |
| 01/17/2007 | EP1078072B1 New peptide fragments for protein purification |
| 01/17/2007 | EP1076704B1 Il-2 selective agonists and antagonists |
| 01/17/2007 | EP0977896B1 Diagnostic system and method for determining the presence of a genotoxic compound in a sample |
| 01/17/2007 | EP0959689B1 Frozen confectionery products |
| 01/17/2007 | EP0954588B1 Ob fusion protein compositions and methods |
| 01/17/2007 | EP0920520B1 Nucleotide sequence coding for an enzyme having a acetolactate synthase activity, plant cell and plant containing it. |
| 01/17/2007 | EP0832970B1 Process for producing nucleoside-5'-phosphate ester |
| 01/17/2007 | EP0687272B1 Method and compositions for recombinant osteogenic protein production |
| 01/17/2007 | EP0220273B2 Synthetic antigens for the detection of aids-related disease |
| 01/17/2007 | CN1898561A Animal model for protease activity and liver damage |
| 01/17/2007 | CN1898392A Process for preparing l-amino acids using strains of the enterobacteriaceae family |
| 01/17/2007 | CN1898390A Promoters for expression in modified vaccinia virus ankara |
| 01/17/2007 | CN1898389A Sugar and lipid metabolism regulators in plants vi |
| 01/17/2007 | CN1898388A Pgro expression units |